alternatives to glp 1 meds GLP-1 Medications Infographic Promising New Science on Weight

The studies in the SURPASS program were similarly designed in terms of tirzepatide dosages, beginning with an initial dose of 2.5 mg administered weekly, followed by increments of 2.5 mg every four weeks until the final randomized treatment doses of 5, 10, or 15 mg of tirzepatide were achieved

Ridker, P

A structured metabolic nutrition strategy like the one Fueled Framework is built around gives GLP-1 users a clear system for managing these challenges while still progressing toward their health and body composition goals

10.2337/dc10-1949

Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon